Interestingly, according to the ADT data, the established CML stem cell markers CD25, CD26, and CD93 could only capture a fraction of the primitive cells (Figure 3—figure supplement 2C). This evidence concerns the gene CD93 and chronic myelogenous leukemia, BCR-ABL1 positive.